ACH logo

ACCENDRA HEALTH INC

ACHNYSE
πŸ† #2732 by market capUS Equity
$1.24β–Ό $0.14 (βˆ’11.11%)
Live
1hβ€”
24hβ–Ό 11.1%
7dβ–Ό 58.0%
14dβ–Ό 62.8%
30dβ–Ό 63.3%
1yβ–Ό 77.3%
🏦Market Cap
$95M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-74.7%
Declining
πŸ“ŠGross Margin
46.0%
Healthy
πŸ’΅FCF Margin
2.2%
Thin
βš–οΈP/S Ratio
0.1x
Cheap
Otter Score
52
Weak

Trading Snapshot

Day Range
$1.23 – $1.25
52-Week Range
$1.24 – $7.10
Volume
$3.84B
Avg Volume
$2.60B
Shares Outstanding
76.6M
Next Earnings
Oct 7, 2026

Fundamentals Snapshot

Annual Revenue
$2.76B
Last Q Revenue
$613M
P/E Ratio
β€”
P/S Ratio
0.1x
EPS (TTM)
$-14.06
Dividend Yield
β€”

Why Investors Own ACH

  • βœ“High-growth profile β€” revenue up -0.7% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 28% gross margin and 21% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$2.76Bβ–² +3.6% YoY
Gross Margin (TTM)
28.1%β–² +3.0% YoY
Operating Income (TTM)
$666Mβ–² +3.6% YoY
Free Cash Flow (TTM)
$580Mβ–² +3.6% YoY

About ACCENDRA HEALTH INC

Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$1.63
β–² +31.4% Upside
High Target$1.77
Low Target$1.45
Based on 16 analysts

Latest News & Updates